Psy44 - Tocilizumab in Combination With Corticosteroids for the Treatment of Giant Cell Arteritis: A Budget Impact Analysis in Italy

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2621
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Psy108 - Cost-Utility Analysis of Tocilizumab in Combination With Corticosteroids for the Treatment of Giant Cell Arteritis in Italian Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Design of the Tocilizumab in Giant Cell Arteritis Trial

International Journal of Rheumatology
RheumatologyImmunology
2013English

Budget Impact Analysis of Paliperidone Palmitate 3-Monthly for the Treatment of Schizophrenia in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

The Treatment of Giant Cell Arteritis in Different Clinical Settings

Frontiers in Immunology
AllergyImmunology
2019English

Endovascular Treatment of Intracerebral Giant Cell Arteritis

Frontiers in Neurology
Neurology
2020English

Glucocorticoid Doses and Acute-Phase Reactants at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2019English

Pcn82 - Budget Impact Analysis of Alectinib for the Treatment of Patients With Untreated Alk-Rearranged NSCLC in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Role of Oral Cyclophosphamide in the Treatment of Giant Cell Arteritis

Rheumatology
RheumatologyPharmacology
2012English

Treatment of Polymyalgia Rheumatica and Giant Cell Arteritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy